NVDA+0.84%AAPL−2.51%GOOGL−1.17%MSFT−2.04%AMZN−0.15%TSM+2.85%SPCX−1.20%AVGO+0.21%
StockVS

NASDAQ · USD

NeuroSense Therapeutics Ltd. (NRSNW) Stock Analysis

NeuroSense Therapeutics Ltd. (NRSNW) is a stock listed on NASDAQ and quoted in US Dollar.

NRSNW

$0.05

+$0.00 (+9.65%)

Sep 2, 2026 · Market close

This is a derivative instrument — a warrant on NeuroSense Therapeutics Ltd. (NRSN) common stock.

Issuer fundamentals are shown on the issuer page, not here.

View NRSN →

Price History

Hover for the daily close. The dotted line marks the period open.

NRSNW Key Statistics

As of Sep 2, 2026
Trading
Open
$0.30
Previous Close
$0.05
Day's Range
0.05–0.06
52-Week Range
0.05–0.06
Volume
6
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
1.58

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

NRSNW Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)−85.72%
2025 (partial year)−10.18%

As of September 2, 2026.

Recent News

News provided by third-party sources. Not financial advice.

About NeuroSense Therapeutics Ltd.

NeuroSense Therapeutics Ltd., a clinical-stage biotechnology company, focuses on discovering and developing treatments for patients suffering from neurodegenerative diseases in the United States and internationally. The company's lead product is PrimeC, an extended-release oral formulation of a fixed-dose combination of ciprofloxacin and celecoxib, currently under Phase 2b/3 clinical trials for the treatment of amyotrophic lateral sclerosis, and completed Phase 2 clinical trials for the treatment of Alzheimer's, as well as under preclinical studies for the treatment of Parkinson's disease. Its preclinical pipeline includes StabiliC for the treatment of Parkinson's disease; and CogniC for the treatment of Alzheimer's disease. NeuroSense Therapeutics Ltd. was incorporated in 2017 and is headquartered in Herzliya, Israel.

Visit website →